Pay in 4 interest-free payments of $5.50 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
Epub 2011 Aug 24
This review focuses principally on GLP-1 RAs approved for treating both T2DM and obesity: liraglutide, semaglutide, and tirzepatide
[Cellular uptake of TPS-L-carnitine synthesised as transporter-based renal targeting [PMID: 23387232] Laboratory literature summary: [Cellular uptake of TPS-L-carnitine synthesised as transporter-based renal targeting prodrug]
Injury Recovery and Tissue Repair The peptide accelerates healing of muscle tears, tendon injuries, and connective tissue damage by promoting cellular proliferation and collagen synthesis
US$ 28.39
US$ 20.74
US$ 27.12
US$ 22.58
US$ 20.08
US$ 20.92
US$ 27.31
US$ 23.07
US$ 24.48
US$ 24.43
US$ 28.30
US$ 24.27
